Skip to main content
SupplementScience

Policosanol — Frequently Asked Questions

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Frequently Asked Questions

Why do Cuban studies show different results than other countries?

This is the central controversy around policosanol. Nearly all studies showing dramatic LDL reductions (20-30%) originate from one Cuban research group. When independent researchers in Germany, South Africa, Italy, and the Netherlands attempted to replicate these findings using the same dose and even Cuban-sourced policosanol, they found little to no effect on cholesterol. Possible explanations include methodological differences, population genetics, dietary factors, or publication bias. Most independent reviewers consider the cholesterol-lowering claims unproven.

Should I take policosanol for cholesterol?

Given the failed replication of Cuban findings, policosanol is not a first-choice supplement for cholesterol management. Better-proven alternatives include plant sterols (6-15% LDL reduction, endorsed by AHA), red yeast rice (15-25% LDL reduction), and bergamot (20-30% LDL reduction). If you choose to try policosanol, it is very safe and well-tolerated, but set realistic expectations — meaningful cholesterol reduction is not guaranteed.

Does the source of policosanol matter?

Possibly. The Cuban studies used a specific sugar cane-derived policosanol with a defined ratio of long-chain alcohols (primarily octacosanol). Rice bran and beeswax policosanol have different compositions, and there is virtually no clinical data supporting their use for cholesterol. Even Cuban-sourced policosanol failed in independent trials, so the source alone does not explain the discrepancy. Until the controversy is resolved, no source of policosanol can be reliably recommended for cholesterol lowering.

References

  1. (). Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA. DOI
  2. (). Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clinical Pharmacology & Therapeutics. DOI